ETFs
B
BIIB
Biogen Inc
209.83
-0.82-0.39%After Hours: 210.03 +0.20 +0.10%19:34 08/14 EDT
OPEN/PREV CLOSE208.36/209.83
TODAY RANGE207.62-210.49
VOL4
MARKET CAP30.90B
52 WEEK RANGE131.52-219.72
AVG VOL (3M)1.19M
% TURNOVER0.42%
TURNOVER176.53M
P/E (TTM)37.04
% RANGE1.36%
EPS(TTM)5.65
P/E(FORWARD)35.75
P/B1.639
BVPS127.61
DIVIDEND--
P/S3.102
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP30.77B
SHARES OUTSTANDING147.75M
NEXT EARNINGS10/28-11/02
FREE FLOAT147.10M
LOT SIZE1
EX-DATE02/02/2017
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Wolfe upgrades Biogen to Outperform on late-stage pipeline
Simply Wall St·1d ago
Biogen (BIIB) Stock Stays Cheap on Cash Flow but Pricey on Earnings
Seeking Alpha·3d ago
Lantheus gains FDA nod for tau PET imaging agent in Alzheimer’s
Dow Jones·4d ago
Biogen Price Target Announced at $300.00/Share by Wolfe Research
Dow Jones·4d ago
Biogen Raised to Outperform From Peer Perform by Wolfe Research
TipRanks·5d ago
Barclays Keeps Their Hold Rating on Biogen (BIIB)
Seeking Alpha·6d ago
Regeneron, Tenet leads top healthcare companies with highest earnings beats
Simply Wall St·08/09 03:47
Should Biogen’s Profit Squeeze Amid Rising New-Therapy Sales Prompt Action From Biogen (BIIB) Investors?
The Motley Fool·08/08 00:02
Biogen (BIIB) Q2 2026 Earnings Call Transcript
Simply Wall St·08/07 19:31
Is Biogen (BIIB) Fully Priced After Earnings Raised Revenue But Cut Profit?
Same Industry
Name/Symbol
Change%
Price